flumazenil has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Excerpt | Relevance | Reference |
---|---|---|
"Severe neutropenia was resolved by G-CSF treatment without CML progression." | 1.37 | [Chronic myelogenous leukemia complicated by drug-induced agranulocytosis]. ( Hino, M; Koh, KR; Nakamae, H; Nakane, T; Nakao, T; Terada, Y; Yamane, T; Yoshida, N, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakao, T | 1 |
Yoshida, N | 1 |
Nakane, T | 1 |
Terada, Y | 1 |
Nakamae, H | 1 |
Koh, KR | 1 |
Yamane, T | 1 |
Hino, M | 1 |
1 other study available for flumazenil and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].
Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Gra | 2011 |